Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Pathology and Clinical Laboratory Medicine, |
RCV001824178 | SCV002073804 | likely pathogenic | Meckel syndrome, type 1 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001882748 | SCV002242965 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2023-12-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr376Asnfs*3) in the MKS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MKS1 are known to be pathogenic (PMID: 19466712, 24886560, 26490104). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Meckel–Gruber syndrome (PMID: 23169490). ClinVar contains an entry for this variant (Variation ID: 1252059). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV003146224 | SCV003830961 | likely pathogenic | not provided | 2022-01-10 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001824178 | SCV001870498 | pathogenic | Meckel syndrome, type 1 | 2021-04-29 | no assertion criteria provided | research |